{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:10:05Z","timestamp":1749053405394,"version":"3.41.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.xphs.2016.06.024","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T18:37:38Z","timestamp":1470422258000},"page":"3199-3204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats"],"prefix":"10.1016","volume":"105","author":[{"given":"Hirokazu","family":"Katayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manami","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Hatae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2016.06.024_bib1","series-title":"Pharmacotherapy: A Pathophysiologic Approach","first-page":"4","article-title":"Clinical pharmacokinetics and individualization of drug therapy","author":"Bauer","year":"1989"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.024_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2125.1983.tb02151.x","article-title":"Pharmacokinetics of valproic acid in young and elderly subjects","volume":"16","author":"Bryson","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 5","key":"10.1016\/j.xphs.2016.06.024_bib3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1528-1157.1995.tb06005.x","article-title":"The effect of age on pharmacokinetics of antiepileptic drugs","volume":"36","author":"Willmore","year":"1995","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.024_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.024_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","article-title":"Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin","volume":"42","author":"De Turck","year":"1998","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.024_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/clpt.1986.144","article-title":"The effect of aspirin on valproic acid metabolism","volume":"40","author":"Abbott","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2016.06.024_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/clpt.1980.192","article-title":"Valproic acid dosage and plasma protein binding and clearance","volume":"28","author":"Bowdle","year":"1980","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.024_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1442-200X.1990.tb00799.x","article-title":"Secondary carnitine deficiency in handicapped patients receiving valproic acid and\/or elemental diet","volume":"32","author":"Igarashi","year":"1990","journal-title":"Acta Pediatr Jpn"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.024_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0009-8981(89)90185-X","article-title":"Carnitine deficiency associated with anticonvulsant therapy","volume":"181","author":"Rodriguez-Segade","year":"1989","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.xphs.2016.06.024_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11095-006-9002-9","article-title":"Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid","volume":"23","author":"Okamura","year":"2006","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.024_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1620\/tjem.167.89","article-title":"The effect of carnitine on the metabolism of valproic acid in epileptic patients","volume":"167","author":"Sakemi","year":"1992","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.024_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1011042008169","article-title":"Up-regulation of carnitine transporters helps maintain tissue carnitine levels in carnitine deficiency induced by pivalic acid","volume":"18","author":"Okudaira","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.06.024_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9673(00)96121-1","article-title":"Determination of valproic acid and its metabolites by gas chromatography-mass spectrometry with selected ion monitoring","volume":"399","author":"Tatsuhara","year":"1987","journal-title":"J\u00a0Chromatogr"},{"issue":"10","key":"10.1016\/j.xphs.2016.06.024_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/jps.2600711013","article-title":"Moment analysis for the separation of mean in\u00a0vivo disintegration, dissolution, absorption, and disposition time of ampicillin products","volume":"71","author":"Tanigawara","year":"1982","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.024_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.36.4.757","article-title":"Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans","volume":"36","author":"Totsuka","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.xphs.2016.06.024_bib16","first-page":"926","article-title":"Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients","volume":"46","author":"Fujii","year":"1993","journal-title":"Jpn J Antibiot"},{"issue":"5","key":"10.1016\/j.xphs.2016.06.024_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/ped.12305","article-title":"Newborn hypocarnitinemia due to long-term transplacental pivalic acid passage","volume":"56","author":"Nasu","year":"2014","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.024_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0009-9236(02)17636-3","article-title":"Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil","volume":"73","author":"Brass","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.024_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1620\/tjem.175.43","article-title":"Alteration of ammonia and carnitine levels in short-term treatment with pivalic acid-containing prodrug","volume":"175","author":"Ito","year":"1995","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.024_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0887-8994(97)00211-7","article-title":"Effect of carnitine on valproic acid concentrations in serum, brain, and liver","volume":"18","author":"Sakemi","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.xphs.2016.06.024_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"5","author":"Gugler","year":"1980","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.024_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1528-1157.1981.tb04098.x","article-title":"Concentration of metabolites of valproic acid in plasma of epileptic patients","volume":"22","author":"L\u00f6scher","year":"1981","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.xphs.2016.06.024_bib23","first-page":"329","article-title":"Pharmacokinetics of valproic acid and its metabolites","volume":"16","author":"Tatsuhara","year":"1990","journal-title":"Jpn J Hosp Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2016.06.024_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00498258409151426","article-title":"Aspects of the metabolism of valproic acid","volume":"14","author":"Granneman","year":"1984","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.024_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-9556(25)08331-X","article-title":"Impaired biliary elimination of beta-glucuronidase-resistant \u201cglucuronides\u201d of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers","volume":"14","author":"Dickinson","year":"1986","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.024_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-2952(85)90111-X","article-title":"Oxidation and glucuronidation of valproic acid in male rats\u2014influence of phenobarbital, 3-methylcholanthrene, beta-naphthoflavone and clofibrate","volume":"34","author":"Heinemeyer","year":"1985","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2016.06.024_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)31879-3","article-title":"Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect","volume":"211","author":"Dickinson","year":"1979","journal-title":"Pharmacol Exp Ther"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916415224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916415224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:29:55Z","timestamp":1749050995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916415224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0022354916415224"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.06.024","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}